We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current GANX market cap is 66.31M. The company's latest EPS is USD -0.8335 and P/E is -2.90.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.73M | -4.89M | -4.41M | -4.38M | -8.18M |
| Net Income | -7.69M | -4.72M | -4.57M | -4.01M | -8.14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 41k | 29k | 196k | 140k | 55k |
| Operating Income | -2.1M | -3.48M | -13.8M | -17.78M | -22.25M |
| Net Income | -2.19M | -3.58M | -13.86M | -17.59M | -22.11M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.26M | 14.1M | 18.61M | 14.58M | 19.2M |
| Total Liabilities | 7.17M | 6.77M | 6.03M | 5.94M | 7.41M |
| Total Equity | 11.09M | 7.33M | 12.58M | 8.64M | 11.79M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 660k | 9.6M | 38.99M | 24.1M | 18.61M |
| Total Liabilities | 1.11M | 3.4M | 4.17M | 5.22M | 6.03M |
| Total Equity | -450k | 6.2M | 34.82M | 18.88M | 12.58M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.24M | -13.21M | -18.87M | -3.59M | -9.34M |
| Investing | 5.15M | 7.08M | 10.22M | 3.02M | 5.02M |
| Financing | 2.95M | 3.08M | 12.64M | -146k | 9.89M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.87M | -3.24M | -12.37M | -14.69M | -18.87M |
| Investing | -14k | -21k | -94k | -14.78M | 10.22M |
| Financing | 1.75M | 10.49M | 41.77M | -79k | 12.64M |
| Market Cap | 66.31M |
| Price to Earnings Ratio | -2.90 |
| Price to Sales Ratio | 1.15k |
| Price to Cash Ratio | 5.44 |
| Price to Book Ratio | 5.1 |
| Dividend Yield | - |
| Shares Outstanding | 26.53M |
| Average Volume (1 week) | 540.55k |
| Average Volume (1 Month) | 243.3k |
| 52 Week Change | -32.98% |
| 52 Week High | 5.33 |
| 52 Week Low | 0.89 |
| Spread (Intraday) | 3.7 (61.67%) |
| Company Name | Gain Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.gaintherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
